Dersimelagon (MT-7117; WHO-10832) is a novel, oral and potent MC1R/melanocortin receptor agonist. It significantly boosted sunlight tolerance in patients with erythropoietic protoporphyria in a multicenter, phase 2 trial.

纯度：≥98%

CAS：1835256-48-8